ARTICLE | Company News
MDxHealth, Teva sales and marketing update
February 3, 2014 8:00 AM UTC
MDxHealth granted Teva exclusive rights to commercialize PredictMDx for Glioblastoma and ConfirmMDx for Prostate Cancer tests in Israel under a three-year deal. MDxHealth will perform the epigenetic...